Cargando…
Existing trial data do not support that hydroxyethyl starch is less harmful when given on more ‘correct’ indications
Autores principales: | Haase, Nicolai, Müller, Rasmus G, Perner, Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056632/ https://www.ncbi.nlm.nih.gov/pubmed/24229437 http://dx.doi.org/10.1186/cc13111 |
Ejemplares similares
-
Is hydroxyethyl starch 130/0.4 safe?
por: Haase, Nicolai, et al.
Publicado: (2012) -
Quality of life and pruritus in patients with severe sepsis resuscitated with hydroxyethyl starch long-term follow-up of a randomised trial
por: Wittbrodt, Piotr, et al.
Publicado: (2013) -
Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis
por: Haase, Nicolai, et al.
Publicado: (2013) -
Markers of endothelial dysfunction in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs. ringer's acetate
por: Müller, RB, et al.
Publicado: (2015) -
Debate on HES safety is important, but must be based on facts
por: Haase, Nicolai, et al.
Publicado: (2013)